High expression of ID2 has also been observed in colorectal cancer samples, and intraperitoneal injection of ID2 siRNA reduces the growth of colorectal tumors in mice, suggesting that ID2 could be a potential drug target for cancer treatment [38]. The gene discussed is ID2; the disease is cancer.